See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Community Videos on Diabetes Health TV

Medi-Peds® Comforting Therapeutic Socks and Shoes

Robb Sackett, Senior V.P. Sales and Marketing

Medi-Peds® Comforting Therapeutic Socks and Shoes

Diabetes Investing

David Kliff

Diabetes Investing

Research with Pig Islets

Bernhard J. Hering, M.D.

Research with Pig Islets

Novo Nordisk Archives

Novo Nordisk

Page 4
DiabetesSisters' National Conference Addresses Unique Challenges of Women with Diabetes

RALEIGH, NC- DiabetesSisters is pleased to announce that registration for the 2011 Weekend for Women Conference in Raleigh, NC will open on January 1, 2011 at 8am.  The Conference, a revolutionary national weekend conference designed specifically for women with diabetes, will take place April 29 - May 1, 2011 at the Marriott City Center in downtown Raleigh.    

Comments 0 comments - Jan 5, 2011 - * * * * *

Charlie Kimball to Pilot New IndyCar Entry

Novo Nordisk, a world leader in diabetes care, has partnered with Chip Ganassi Racing, LLC to create the Novo Nordisk Chip Ganassi Racing team for the 2011 IZOD IndyCar season. The team will sponsor a new entry in the series driven by American racecar driver Charlie Kimball. This partnership makes Kimball one of the first drivers from the 2010 Firestone Indy Lights series to move up the official "Road to Indy" with a full season sponsorship.

Comments 0 comments - Dec 16, 2010 - * * * * *

Twenty Community-Based Organizations Across the United States Receive Awards to Encourage Seniors to Get Screened for Diabetes

Leaders of the Medicare Diabetes Screening Project (MDSP) announced that twenty community-based organizations from 17 states were given awards of $2,500 each to be used to encourage seniors ages 65 and older who are covered under Medicare to get screened for diabetes.

Comments 0 comments - Dec 10, 2010 - * * * * *

Calibra Gains FDA Clearance to Market Finesse

Calibra Medical has announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its FinesseTM insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid-acting insulin. This much-anticipated step closer to market release follows the announcement in January that Calibra received FDA clearance for the device for use with Eli Lilly's Humalog® rapid-acting insulin.

Comments 0 comments - Oct 18, 2010 - * * * * *

Novo Nordisk Creates "App" to Help Doctors Dose Insulin

Novo Nordisk announced today the availability of NovoDoseTM - the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood glucose goals for their patients with diabetes, a disease that affects nearly 24 million Americans. The guide is available as an application on iTunes and is specific to Novo Nordisk's modern insulin analog portfolio: Levemir® (insulin detemir [rDNA origin] injection), NovoLog® (insulin aspart [rDNA origin] injection), and NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]).

Comments 0 comments - Aug 24, 2010 - * * * * *

Victoza® Achieved Improved Blood Sugar Control in African-Americans With Type 2 Diabetes

Novo Nordisk presented results demonstrating that once-daily Victoza® (liraglutide [rDNA] injection) achieved significantly greater improvements in blood sugar control compared to placebo among African-American patients with type 2 diabetes. The meta-analysis of phase 3 data from the Liraglutide Effect and Action in Diabetes (LEAD) trials were presented at the 2010 National Medical Association Annual Convention & Scientific Assembly.

Comments 0 comments - Aug 5, 2010 - * * * * *

Pump and Sensor Combo Beats MDI Decisively in Medtronic’s STAR 3 Study

A massive study involving 485 people with type 1 diabetes at 30 locations across North America shows that the combination of an insulin pump and a continuous glucose monitor helps patients achieve significantly lower A1c levels than multiple daily insulin injections.

Comments 0 comments - Jul 13, 2010 - * * * * *

More from ACCORD

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was compared with standard glucose control.

Comments 0 comments - Jul 2, 2010 - * * * * *

Academia, Biotech and the Pharmaceutical Industry Have Joined Forces to Fight Diabetes

IMIDIA ("Innovative Medicines Initiative for Diabetes"), a public private consortium funded by the Innovative Medicines Initiative (IMI), announced today the launch of a project focusing on pancreatic islet cell function and survival. Academia, biotech and pharma industry have joined forces to develop biomarkers and tools to pave the way for improved disease management and ultimately provide a cure for diabetes.

Comments 0 comments - Jun 18, 2010 - * * * * *

Novo Nordisk Introduces New Industry Resource for Information on Diabetes and Chronic Disease

Novo Nordisk, a global healthcare company and leader in diabetes care, announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.

Comments 0 comments - Apr 4, 2010 - * * * * *

Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.